1Steppan CM, Lazar MA. The current biology of resistin. J Intern Med, 2004, 255: 439-447.
2Cohn JN. Vascular wall function as a risk marker for cardiovascular disease. J hypertens, 1999,17 Suppl 5 : s41 -s44.
3Furuhashi M, Ura N, Higashiura K, et al. Circulating resistin levels in essential hypertension. Clin Endocrinol, 2003, 59 : 507- 510.
4Steppan CM, Brown EJ, Wright CM. A family of tissue specific resistin like molecules. Proc Natl Acad Sci USA, 2001,98 : 502- 506.
5Patel SD, Rajala MW, Rossetti L, et al. Disulfide-dependent multimeric assembly of resistin family hormones. Science, 2004, 304 : 1154-1158.
6Patel L, Buckls AC, Kin Ghom IJ, et al. Resistin is expressed in human macrophages and directly by PPAR gamma activators. Biochem Biophys Res Commun, 2003, 300: 472-476.
7Asmar R, Benetos A, London G, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press, 1995,4:48-54.
8Kobayashi K, Akishita M, Yu W, et al. Interrelationship between non-invasive measurements of atherosclerosis : flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis, 2004,173 : 13-18.
9Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res, 2003, 26:615-622.
10Shin HJ, Park S, Yoon SJ, et al. Association between serum resistin and carotid intima-media thickness in hypertension patients. Int J Cardiol, 2008,125,1:79-84.
